Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 28.95%7.02B | 126.90%5.15B | -59.53%1.64B | -17.66%18.81B | 48.29%7.05B | -28.08%5.45B | -64.06%2.27B | -3.65%4.04B | -8.44%22.84B | -36.01%4.75B |
| Net income from continuing operations | -87.98%188M | -31.46%941M | -6.05%1.29B | -12.05%4.29B | -102.79%-23M | -12.18%1.56B | -32.26%1.37B | 469.29%1.37B | -58.86%4.87B | -66.67%824M |
| Depreciation and amortization | -0.77%2.06B | -3.80%2.05B | -1.69%2.04B | -3.59%8.39B | 1.25%2.1B | -6.98%2.08B | -5.71%2.13B | -2.49%2.07B | 2.73%8.7B | -3.76%2.08B |
| Asset impairment expenditure | ---- | ---- | ---- | 5.84%4.48B | 218.58%4.48B | --0 | --0 | --0 | 449.22%4.23B | --1.41B |
| Remuneration paid in stock | -201.59%-319M | ---- | ---- | 214.67%508M | 170.17%167M | 460.92%314M | ---- | ---- | -119.75%-443M | -1,222.22%-238M |
| Remuneration paid in stock | 15.47%209M | -17.89%179M | 17.82%410M | 21.95%911M | 31.20%164M | 39.23%181M | 21.79%218M | 11.18%348M | 11.33%747M | -5.30%125M |
| Deferred tax | 169.68%193M | -1,600.00%-272M | 92.80%-28M | 49.84%-1.45B | 44.86%-767M | 67.90%-277M | 95.65%-16M | -45.69%-389M | -49.61%-2.89B | -169.57%-1.39B |
| Other non cashItems | 209.81%2.59B | 85.78%3.57B | 30.15%505M | -7.09%4.47B | -12.13%1.33B | 330.30%836M | 7.56%1.92B | -79.36%388M | 53.02%4.81B | -35.92%1.51B |
| Change In working capital | 67.07%1.25B | 83.38%-562M | -1,144.53%-2.58B | -198.90%-2.78B | -189.62%-397M | -71.45%750M | -710.47%-3.38B | 130.46%247M | 3,092.55%2.81B | -47.64%443M |
| -Change in receivables | -145.35%-156M | -109.55%-17M | -110.68%-1.48B | 213.64%207M | 14.16%387M | 17,100.00%344M | 322.50%178M | -260.00%-702M | 104.54%66M | 181.49%339M |
| -Change in inventory | 103.13%2M | -7.69%-56M | -106.67%-155M | 23.50%-319M | -233.33%-128M | -16.36%-64M | 80.95%-52M | 59.46%-75M | 39.21%-417M | 156.47%96M |
| -Change in prepaid assets | -42.11%88M | 1,384.00%371M | -321.13%-628M | 292.02%361M | 82.82%-100M | 39.45%152M | -94.47%25M | 270.06%284M | 28.79%-188M | -185.29%-582M |
| -Change in payables and accrued expense | 547.94%1.73B | 130.31%515M | -292.27%-696M | -95.39%177M | 596.65%1.25B | -89.48%267M | -207.94%-1.7B | 180.27%362M | 117.07%3.84B | -85.99%179M |
| -Change in other working capital | -905.88%-411M | 25.03%-1.38B | 0.00%378M | -557.38%-3.21B | -538.69%-1.8B | 54.55%51M | -63.90%-1.83B | 102.14%378M | -190.04%-488M | 14.80%411M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 28.95%7.02B | 126.90%5.15B | -59.53%1.64B | -17.66%18.81B | 48.29%7.05B | -28.08%5.45B | -64.06%2.27B | -3.65%4.04B | -8.44%22.84B | -36.01%4.75B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 60.47%-3.26B | -7.17%-1.18B | 92.33%-735M | -936.34%-20.82B | -134.25%-1.87B | -2,137.40%-8.26B | -223.17%-1.1B | -1,821.44%-9.59B | -222.47%-2.01B | -78.57%-800M |
| Net PPE purchase and sale | -53.01%-381M | -11.62%-269M | -21.76%-235M | -25.35%-974M | -41.95%-291M | -13.70%-249M | -35.39%-241M | -10.29%-193M | -11.80%-777M | 3.76%-205M |
| Net business purchase and sale | 67.01%-2.8B | -11.51%-940M | 94.27%-538M | -1,577.60%-20.52B | -224.05%-1.79B | -5,309.55%-8.49B | -426.88%-843M | -2,559.77%-9.39B | -54.03%-1.22B | -84.33%-553M |
| Net investment purchase and sale | -100.83%-4M | 61.54%-5M | --22M | 2,290.91%482M | 160.00%12M | 16,200.00%483M | -550.00%-13M | --0 | -123.91%-22M | -133.33%-20M |
| Net other investing changes | -2,666.67%-77M | 760.00%33M | 366.67%16M | 1,353.85%189M | 995.45%197M | -70.00%3M | -400.00%-5M | -123.08%-6M | -98.32%13M | -540.00%-22M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 60.47%-3.26B | -7.17%-1.18B | 92.33%-735M | -936.34%-20.82B | -134.25%-1.87B | -2,137.40%-8.26B | -223.17%-1.1B | -1,821.44%-9.59B | -222.47%-2.01B | -78.57%-800M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -49.41%-4.59B | 55.55%-2.71B | -111.63%-1.26B | 69.74%-5.21B | -54.21%-6.86B | -15.45%-3.07B | -55.54%-6.1B | 274.73%10.82B | 30.56%-17.22B | 53.82%-4.45B |
| Net issuance payments of debt | -340.45%-1.78B | 106.24%209M | -82.77%2.56B | 277.15%7.35B | -109.70%-3.76B | -20,050.00%-403M | -234.13%-3.35B | 1,200.15%14.86B | 66.63%-4.15B | 73.81%-1.79B |
| Net common stock issuance | 76.47%-4M | -33.33%-12M | 27.42%-961M | 13.39%-1.71B | -11,833.33%-358M | -325.00%-17M | 10.00%-9M | 32.28%-1.32B | -32.62%-1.97B | 25.00%-3M |
| Cash dividends paid | -5.82%-2.91B | -5.82%-2.91B | -5.52%-2.93B | -4.61%-11.03B | -4.80%-2.75B | -4.72%-2.75B | -4.76%-2.75B | -4.17%-2.77B | -4.94%-10.54B | -4.79%-2.63B |
| Proceeds from stock option exercised by employees | -5.97%63M | -50.00%5M | -55.91%56M | 18.89%214M | -67.74%10M | 86.11%67M | -79.17%10M | 95.38%127M | -31.30%180M | -41.51%31M |
| Net other financing activities | 15.63%37M | ---2M | 114.67%11M | 94.34%-42M | 101.75%1M | 150.00%32M | --0 | 74.14%-75M | 32.67%-742M | 82.52%-57M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -49.41%-4.59B | 55.55%-2.71B | -111.63%-1.26B | 69.74%-5.21B | -54.21%-6.86B | -15.45%-3.07B | -55.54%-6.1B | 274.73%10.82B | 30.56%-17.22B | 53.82%-4.45B |
| Net cash flow | ||||||||||
| Beginning cash position | -50.75%6.47B | -71.36%5.18B | -56.89%5.52B | 39.27%12.81B | -45.38%7.26B | 49.90%13.13B | 169.21%18.07B | 39.27%12.81B | -5.59%9.2B | 12.30%13.29B |
| Current changes in cash | 85.89%-830M | 125.61%1.26B | -106.79%-358M | -300.25%-7.23B | -240.12%-1.69B | -229.42%-5.88B | -339.46%-4.93B | 311.01%5.27B | 847.00%3.61B | 81.31%-496M |
| Effect of exchange rate changes | -200.00%-8M | 433.33%30M | 150.00%9M | -1,400.00%-65M | -300.00%-46M | 150.00%8M | 10.00%-9M | -325.00%-18M | 108.06%5M | 0.00%23M |
| End cash Position | -22.43%5.63B | -50.75%6.47B | -71.36%5.18B | -56.89%5.52B | -56.89%5.52B | -45.38%7.26B | 49.90%13.13B | 169.21%18.07B | 39.27%12.81B | 39.27%12.81B |
| Free cash from | 27.80%6.64B | 140.59%4.88B | -63.61%1.4B | -19.17%17.83B | 48.57%6.76B | -29.33%5.2B | -66.94%2.03B | -4.26%3.85B | -9.02%22.06B | -36.96%4.55B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.